Associated Papers
High-risk pathogenic germline variants in blood relatives of BRCA1/2 negative probands.
Yoshida R et al.
Breast Cancer (tokyo, Japan), 2024
39003386 (PubMed )
Supplement: 12282_2024_1615_MOESM3_ESM.xlsx › Table_S3
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab.
Lin DI et al.
Npj Precision Oncology, 2024
39277692 (PubMed )
Supplement: 41698_2024_679_MOESM1_ESM.pdf
Evolutionary origin of germline pathogenic variants in human DNA mismatch repair genes.
Lei H et al.
Human Genomics, 2024
38287404 (PubMed )
Supplement: 40246_2024_573_MOESM3_ESM.xls › MLH1
Clinical and molecular features of pediatric cancer patients with Lynch syndrome.
Scollon S et al.
Pediatric Blood & Cancer, 2022
A survey of the clinicopathological and molecular characteristics of patients with suspected Lynch syndrome in Latin America.
Rossi BM et al.
Bmc Cancer, 2017
Select a paper to view details